Pages that link to "Q41180628"
Jump to navigation
Jump to search
The following pages link to Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells (Q41180628):
Displaying 50 items.
- A specific survival response in dopamine neurons at most risk in Parkinson's disease (Q28115736) (← links)
- Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. (Q31813509) (← links)
- Improvement of sciatic nerve regeneration using laminin-binding human NGF-beta (Q33480007) (← links)
- Neural stem cells -- a versatile tool for cell replacement and gene therapy in the central nervous system (Q33818205) (← links)
- The selective vulnerability of striatopallidal neurons (Q33939097) (← links)
- Cell delivery to the central nervous system (Q34003146) (← links)
- Immortalized neural cell lines for CNS transplantation (Q34120810) (← links)
- The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue (Q34154476) (← links)
- Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease (Q34341619) (← links)
- Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease. (Q34657624) (← links)
- Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions (Q35000414) (← links)
- Gene therapy in mouse models of huntington disease. (Q35090208) (← links)
- Neurotrophins and Neurodegenerative Diseases: Receptors Stuck in Traffic? (Q35117683) (← links)
- Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy (Q35158643) (← links)
- Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology (Q35579484) (← links)
- Neurotrophic factors in Huntington's disease (Q35618345) (← links)
- Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging (Q35894004) (← links)
- Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke. (Q36027146) (← links)
- BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice (Q36191786) (← links)
- Patterned expression of neurotrophic factors and receptors in human limbal and corneal regions (Q36342386) (← links)
- Stem cell transplantation as a therapeutic strategy for traumatic brain injury (Q36368256) (← links)
- Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease (Q36728537) (← links)
- Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. (Q36939755) (← links)
- Biocompatability of carbon nanotubes with stem cells to treat CNS injuries (Q37018785) (← links)
- Neurotrophic factors in neurodegenerative disorders : potential for therapy (Q37322226) (← links)
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease (Q37776087) (← links)
- Concise review: Can stem cells be used to treat or model Alzheimer's disease? (Q38045262) (← links)
- Improvements in biomaterial matrices for neural precursor cell transplantation (Q38521737) (← links)
- Engineered BDNF producing cells as a potential treatment for neurologic disease (Q38829577) (← links)
- In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. (Q38972904) (← links)
- Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke. (Q39065047) (← links)
- Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. (Q39144600) (← links)
- Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate. (Q39759995) (← links)
- BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. (Q39932912) (← links)
- Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum. (Q40210558) (← links)
- Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. (Q40519742) (← links)
- AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease (Q40560840) (← links)
- Nucleic Acid-Based Therapy Approaches for Huntington's Disease (Q40582623) (← links)
- Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease (Q40873179) (← links)
- Tyrosine phosphatase SHP-2 is a mediator of activity-dependent neuronal excitotoxicity. (Q40949874) (← links)
- Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease (Q41087697) (← links)
- Human neural stem cell transplantation into the corpus callosum of Alzheimer's mice (Q42373777) (← links)
- Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study (Q42437412) (← links)
- Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation (Q42451246) (← links)
- AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment (Q43704735) (← links)
- Tyrosine kinase B and C receptors in the neostriatum and nucleus accumbens are co-localized in enkephalin-positive and enkephalin-negative neuronal profiles and their expression is influenced by cocaine (Q44328326) (← links)
- Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. (Q45293425) (← links)
- Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease (Q45298550) (← links)
- Brain-derived neurotrophic factor in Huntington disease (Q45300415) (← links)
- BDNF gene transfer to the mammalian brain using CNS-derived neural precursors (Q45864059) (← links)